Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver): A novel strategy for modifying excitability

David C. Johns, H. Bradley Nuss, Nipavan Chiamvimonvat, Brian M. Ramza, Eduardo Marban, John H. Lawrence

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Excitability is governed primarily by the complement of ion channels in the cell membrane that shape the contour of the action potential. To modify excitability by gene transfer, we created a recombinant adenovirus designed to overexpress a Drosophila Shaker potassium channel (AdShK). In vitro, a variety of mammalian cell types infected with AdShK demonstrated robust expression of the exogenous channel. Spontaneous action potentials recorded from cardiac myocytes in primary culture were abbreviated compared with noninfected myocytes. Intravascular infusion of AdShK in neonatal rats induced Shaker potassium channel mRNA expression in the liver, and large potassium currents could be recorded from explanted hepatocytes. Thus, recombinant adenovirus technology has been used for in vitro and in vivo gene transfer of ion channel genes designed to modify cellular action potentials. With appropriate targeting, such a strategy may be useful in gene therapy of arrhythmias, seizure disorders, and myotonic muscle diseases.

Original languageEnglish (US)
Pages (from-to)1152-1158
Number of pages7
JournalJournal of Clinical Investigation
Volume96
Issue number2
StatePublished - Aug 1995
Externally publishedYes

Fingerprint

Shaker Superfamily of Potassium Channels
Voltage-Gated Potassium Channels
Cardiac Myocytes
Adenoviridae
Action Potentials
Drosophila
Liver
Ion Channels
Genes
Cell Shape
Genetic Therapy
Muscle Cells
Cardiac Arrhythmias
Hepatocytes
Epilepsy
Potassium
Cell Membrane
Technology
Muscles
Messenger RNA

Keywords

  • Gene therapy
  • Heart
  • Ion channels
  • Liver
  • Rats

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver) : A novel strategy for modifying excitability. / Johns, David C.; Nuss, H. Bradley; Chiamvimonvat, Nipavan; Ramza, Brian M.; Marban, Eduardo; Lawrence, John H.

In: Journal of Clinical Investigation, Vol. 96, No. 2, 08.1995, p. 1152-1158.

Research output: Contribution to journalArticle

@article{cb072604b7544f8a9a96500953025a95,
title = "Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver): A novel strategy for modifying excitability",
abstract = "Excitability is governed primarily by the complement of ion channels in the cell membrane that shape the contour of the action potential. To modify excitability by gene transfer, we created a recombinant adenovirus designed to overexpress a Drosophila Shaker potassium channel (AdShK). In vitro, a variety of mammalian cell types infected with AdShK demonstrated robust expression of the exogenous channel. Spontaneous action potentials recorded from cardiac myocytes in primary culture were abbreviated compared with noninfected myocytes. Intravascular infusion of AdShK in neonatal rats induced Shaker potassium channel mRNA expression in the liver, and large potassium currents could be recorded from explanted hepatocytes. Thus, recombinant adenovirus technology has been used for in vitro and in vivo gene transfer of ion channel genes designed to modify cellular action potentials. With appropriate targeting, such a strategy may be useful in gene therapy of arrhythmias, seizure disorders, and myotonic muscle diseases.",
keywords = "Gene therapy, Heart, Ion channels, Liver, Rats",
author = "Johns, {David C.} and Nuss, {H. Bradley} and Nipavan Chiamvimonvat and Ramza, {Brian M.} and Eduardo Marban and Lawrence, {John H.}",
year = "1995",
month = "8",
language = "English (US)",
volume = "96",
pages = "1152--1158",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver)

T2 - A novel strategy for modifying excitability

AU - Johns, David C.

AU - Nuss, H. Bradley

AU - Chiamvimonvat, Nipavan

AU - Ramza, Brian M.

AU - Marban, Eduardo

AU - Lawrence, John H.

PY - 1995/8

Y1 - 1995/8

N2 - Excitability is governed primarily by the complement of ion channels in the cell membrane that shape the contour of the action potential. To modify excitability by gene transfer, we created a recombinant adenovirus designed to overexpress a Drosophila Shaker potassium channel (AdShK). In vitro, a variety of mammalian cell types infected with AdShK demonstrated robust expression of the exogenous channel. Spontaneous action potentials recorded from cardiac myocytes in primary culture were abbreviated compared with noninfected myocytes. Intravascular infusion of AdShK in neonatal rats induced Shaker potassium channel mRNA expression in the liver, and large potassium currents could be recorded from explanted hepatocytes. Thus, recombinant adenovirus technology has been used for in vitro and in vivo gene transfer of ion channel genes designed to modify cellular action potentials. With appropriate targeting, such a strategy may be useful in gene therapy of arrhythmias, seizure disorders, and myotonic muscle diseases.

AB - Excitability is governed primarily by the complement of ion channels in the cell membrane that shape the contour of the action potential. To modify excitability by gene transfer, we created a recombinant adenovirus designed to overexpress a Drosophila Shaker potassium channel (AdShK). In vitro, a variety of mammalian cell types infected with AdShK demonstrated robust expression of the exogenous channel. Spontaneous action potentials recorded from cardiac myocytes in primary culture were abbreviated compared with noninfected myocytes. Intravascular infusion of AdShK in neonatal rats induced Shaker potassium channel mRNA expression in the liver, and large potassium currents could be recorded from explanted hepatocytes. Thus, recombinant adenovirus technology has been used for in vitro and in vivo gene transfer of ion channel genes designed to modify cellular action potentials. With appropriate targeting, such a strategy may be useful in gene therapy of arrhythmias, seizure disorders, and myotonic muscle diseases.

KW - Gene therapy

KW - Heart

KW - Ion channels

KW - Liver

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0029084056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029084056&partnerID=8YFLogxK

M3 - Article

C2 - 7635952

AN - SCOPUS:0029084056

VL - 96

SP - 1152

EP - 1158

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -